Article Information
History
- July 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Susan Johnson1,*,
- Clarissa I Martinez1,
- Clara B Jegede1,
- Samanta Gutierrez1,
- Mario Cortese1,
- C Josefina Martinez1,
- Shaily J Garg1,
- Nadine Peinovich1,
- Emery G Dora1 and
- Sean N Tucker1
- ↵*Corresponding Author
Dr Susan Johnson, 170 Harbor Way, South San Francisco, CA 94080, sjohnson{at}vaxart.com, +1 650-550-3529
Posted July 19, 2022.
SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trial
